Eggshell Membrane Market Size, Share, Trends, Growth and Forecast 2026–2034

Eggshell Membrane Market Overview Analysis By Fortune Business Insights

Market Size & Growth Outlook

According to Fortune Business Insights: The global eggshell membrane market was valued at USD 221.36 million in 2025 and is projected to grow from USD 238.65 million in 2026 to USD 459.62 million by 2034, exhibiting a CAGR of 8.54% during the forecast period. North America dominated the global market with a 37.20% share in 2025, valued at USD 82.35 million.

Eggshell membrane is the thin fibrous layer found between the eggshell and egg white. It contains naturally occurring collagen, elastin, glycosaminoglycans, hyaluronic acid, chondroitin sulfate, glucosamine, and other bioactive proteins — making it a high-value functional ingredient for joint health, skin health, connective tissue support, cartilage protection, mobility supplementation, pet nutrition, and emerging biomedical applications. The market has gained strong relevance as the nutraceutical, pharmaceutical, cosmetics, and functional food and beverage industries increasingly seek natural, upcycled, and clinically positioned bioactive ingredients that align with circular economy principles and consumer wellness priorities.

Get a Sample Research PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/103813

Market Trends

The defining trend shaping the eggshell membrane market is the growing demand for upcycled, natural, and collagen-rich bioactive ingredients across joint health, mobility support, skin health, beauty-from-within, pet supplements, and clean-label nutraceutical products. Eggshell membrane is gaining particular traction as it converts major food-processing by-products — from the global egg industry — into high-value functional ingredients aligned with sustainable sourcing, waste reduction, and circular economy values. The Food and Agriculture Organization reported that global hen egg production reached approximately 91 million tonnes, or nearly 1.7 trillion eggs, in 2023, with China, India, and the U.S. among the largest producers, providing a substantial raw material stream for eggshell membrane extraction. The growing demand for low-dose, multifunctional, and clinically validated natural ingredients is helping drive consistent market growth, particularly among health-conscious consumers seeking science-backed joint health and skin health solutions.

Market Drivers

Rising Demand for Mobility Supplements and Natural Collagen Ingredients: The primary market driver is the growing global demand for joint health and mobility supplements across aging populations, sports nutrition consumers, active adults, and pet health formulations. Eggshell membrane ingredients are valued because they naturally deliver collagen, elastin, hyaluronic acid, chondroitin sulfate, and glucosamine — bioactive components associated with connective tissue support, joint comfort, cartilage protection, flexibility, and skin elasticity — in a single natural ingredient. The World Health Organization estimated that 528 million people globally were living with osteoarthritis in 2019, with 73% of those patients older than 55 years, highlighting the strong structural correlation between global aging demographics and sustained joint health supplement demand. Compared with conventional synthetic joint health ingredients, eggshell membrane can be positioned as a naturally derived, upcycled ingredient with strong clean-label and sustainability appeal.

Market Restraints

Allergen Labeling and Regulatory Compliance: The most significant market restraint is allergen-related compliance, as eggshell membrane is an egg-derived ingredient. In the U.S., the FDA identifies eggs as a major food allergen under federal labeling requirements, meaning food, beverage, and supplement products containing egg-derived ingredients generally require clear allergen disclosure. This creates a commercial limitation for mainstream functional beverage, gummy, protein blend, and wellness snack formulations, where brands increasingly prefer allergen-free, vegan, and plant-based positioning. In Europe, EFSA assessed egg membrane hydrolysate as a novel food and concluded it was safe as a food supplement at 450 mg per day for the general adult population — but this regulatory pathway requires suppliers to provide detailed safety dossiers, production documentation, exposure assessments, and compliance support before wider commercialization, adding cost and timeline complexity.

Market Opportunities

Pet Nutrition Expansion: The pet nutrition segment offers a strong and growing opportunity, particularly for dog joint health, mobility support, senior pet care, and preventive wellness supplements. Pet owners are increasingly treating animals as family members and prioritizing wellness-oriented products that support long-term mobility, comfort, and quality of life. The American Pet Products Association's 2024 Dog and Cat Owner Insight Report highlighted that pet owners continue to prioritize pet health even under economic pressure. Research from the Dog Aging Project in 2022 reported that approximately 70% of dogs with a diagnosis of osteoarthritis were receiving a joint supplement — demonstrating strong consumer acceptance of joint-health supplementation in the pet care segment. In May 2025, IQI Trusted Petfood Ingredients partnered with Spanish biotech company Eggnovo to distribute Ovopet, an upcycled eggshell membrane ingredient, across the North American pet food market, positioning it for joint, skin, coat, and gut health in pets.

Segmentation Analysis

By Type: Hydrolyzed eggshell membrane dominates the market, valued at USD 146.27 million in 2025, owing to its superior compatibility with dietary supplement formulations, functional beverages, powder blends, gummies, and advanced nutraceutical applications. Enzymatic processing improves dispersibility, bioactive accessibility, and formulation flexibility compared to less-processed membrane grades, making hydrolyzed formats the preferred choice for branded, clinically positioned, and standardized ingredient systems. The hydrolyzed segment is also the fastest-growing type, projected at a CAGR of 9.65% through 2034. Unhydrolyzed eggshell membrane, valued at USD 75.09 million in 2025, maintains demand in powder-based nutraceuticals, animal nutrition, and applications where natural membrane structure and cost competitiveness are prioritized.

By Form: Powder dominates the market, valued at USD 119.18 million in 2025, due to its wide adoption as a bulk B2B ingredient format across nutraceutical, cosmetic, functional food, and animal nutrition manufacturers. Powdered eggshell membrane offers better shelf stability, flexible dosage control, compatibility with dry blending, and suitability for incorporation into capsules, tablets, sachets, powdered drinks, pet supplements, and cosmetic ingredient systems. The capsules and tablets segment, valued at USD 73.22 million in 2025, is the fastest-growing form at a CAGR of 10.30% through 2034, reflecting rising finished-product supplement demand in the joint health and healthy aging categories.

By Application: Dietary supplements dominate with a value of USD 120.13 million in 2025, driven by extensive use in joint health, cartilage support, healthy aging, sports recovery, skin health, and mobility products. Eggshell membrane is particularly attractive for supplement formulators because it delivers multiple naturally occurring bioactive components in a single clean-label, upcycled ingredient. Functional food and beverages, valued at USD 21.85 million in 2025, is the fastest-growing application segment, projected at a CAGR of 13.02% through 2034, as functional food innovation expands beyond traditional supplement formats. Cosmetics and personal care, pharmaceuticals and biomedical applications, and animal nutrition are also growing segments as the ingredient gains broader cross-industry validation.

Regional Outlook

North America leads the global market at USD 82.35 million in 2025, projected to reach USD 155.57 million by 2034 at a CAGR of 7.40%. Growth is driven by strong demand for joint health supplements, mobility support products, healthy aging formulations, and pet supplements, supported by a large nutraceutical manufacturing base and high consumer awareness of branded bioactive ingredients. The U.S. dominates at approximately USD 71.53 million in 2025, benefiting from large-scale egg production, extensive supplement retail infrastructure, and high adoption of clinically validated joint health ingredients.

Europe was valued at USD 63.29 million in 2025 and is projected to reach USD 146.35 million by 2034 at a CAGR of 9.84%, the second-highest regional growth rate. Growth is supported by strong demand for premium nutraceuticals, collagen-based beauty supplements, healthy aging products, natural-source ingredients, and circular-economy-aligned ingredient solutions. Germany leads the region at approximately USD 14.64 million in 2025, supported by strong consumer demand for joint health supplements and pharmacy-distributed nutraceuticals, followed by the U.K. at approximately USD 9.00 million.

Asia Pacific was valued at USD 50.54 million in 2025 and is projected to reach USD 120.05 million by 2034 at the fastest regional CAGR of 10.16%. Growth is driven by the region's large egg production base, expanding nutraceutical manufacturing, rising functional food and beverage demand, and increasing awareness of joint health and beauty-from-within products. China leads the region at approximately USD 19.42 million in 2025, while India follows at USD 5.67 million, supported by growing dietary supplement adoption and nutraceutical manufacturing expansion.

South America was valued at USD 14.20 million in 2025 (CAGR of 5.19%), led by Brazil at USD 9.81 million. Middle East & Africa, valued at USD 10.98 million in 2025 (CAGR of 3.75%), represents the smallest but developing market.

Connect with Our Expert for any Queries: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/103813

Competitive Landscape

The global eggshell membrane market is shaped by branded ingredient development, hydrolyzed membrane technology, clinical research investment, sustainability positioning, and application-specific technical support. Key players include Stratum Nutrition (U.S.), Biova LLC (U.S.), Eggnovo S.L. (Spain), Kewpie Corporation (Japan), Microcore Research Laboratories (India), Certified Nutraceuticals Inc. (U.S.), Ecovatec Solutions Inc. (Canada), Dutch Eggmembrane Protein Powder B.V. (Netherlands), Bolise Co. Ltd. (China), and Mitushi Biopharma (India).

Notable recent developments include Stratum Nutrition's August 2025 NutraStrong certification for NEM, Ovolux, and Eggshell Membrane Collagen Support Complex; Stratum's January 2025 launch of Ovolux — an upcycled eggshell membrane collagen ingredient with a published clinical study supporting skin, hair, and nail health; IQI and Eggnovo's May 2025 North American distribution partnership for the Ovopet pet food ingredient; and Stratum Nutrition's December 2021 pre-market approval from India's FSSAI for NEM across dietary supplements, medical foods, novel foods, and nutraceuticals.